Phacilitate Leaders World

Conference speakers

Loading
Dobri Kiprov

Dobri Kiprov

Medical Director, Chief of Immunotherapy Division, Apheresis Care Group, California Pacific Medical Center

Dobri D. Kiprov, M.D. is the Medical Director of Apheresis Care Group and Chief of the Division of Immunotherapy at California Pacific Medical Center in San Francisco, California.  He has worked in the field of therapeutic apheresis for more than 25 years and has published extensively on this subject. He has pioneered numerous applications for therapeutic apheresis including the first to treat patients with an immunoadsorption column in the USA which led to its FDA approval. Dr. Kiprov served two terms on the American Society For Apheresis Board of Directors and created the first ASFA educational video program.  He is also the first physician to take and pass the ASCP sanctioned Hemapheresis Practitioner Exam (HP, ASCP).  Dr. Kiprov is the recipient of the ASFA Presidential Award for his pioneering work and numerous contributions to the field of apheresis and the Society. He has also received the ASFA Lecturer Award and The Francis Morrison Memorial Award.

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK